PharmaNet/i3 has been renamed to inVentiv Health, Inc. to reflect the closer alignment between the clinical segment and the company’s commercial and consulting services.   “As a top global CRO, renaming ourselves inVentiv Health Clinical demonstrates a company-wide commitment to our clinical clients, who will benefit from seamless, global access to a more robust range of services,” said Paul Meister, chief executive officer at inVentiv Health. “Clients can now access broad inVentiv talent with e...